ARQT earnings: a positive outcome, +36.4%

On March 19, 2020, Arcutis Biotherapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +36.4% in the window around the event. It had already run -25.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.